Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:APHA Aphria (APHA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Aphria Stock (NASDAQ:APHA) 30 days 90 days 365 days Advanced Chart Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office... I put all the details together for you here — but please hurry. Get Aphria alerts:Sign Up Key Stats Today's Range$15.38▼$15.3850-Day Range$13.14▼$18.3752-Week Range$2.78▼$32.29VolumeN/AAverage Volume21.83 million shsMarket Capitalization$4.87 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.Read More… Receive APHA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aphria and its competitors with MarketBeat's FREE daily newsletter. Email Address APHA Stock News HeadlinesTilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth OpportunitiesJuly 30, 2024 | markets.businessinsider.comTilray's Aphria RX awarded German cannabis trading licenseJuly 29, 2024 | msn.comDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...December 21, 2024 | Banyan Hill Publishing (Ad)Horse Racing UK & Ireland ResultsMay 21, 2024 | bbc.comSheep Ate 600lbs Of Cannabis While Sheltering From A Storm: Here's What They Did NextSeptember 27, 2023 | benzinga.comEwe Won't Believe It: Greek Sheep's 'Highly' Unconventional Cannabis Greenhouse AdventureSeptember 25, 2023 | markets.businessinsider.comTilray CFO Engages Shareholders On Reddit, Addresses Concerns And Company's Growth StrategyJune 8, 2023 | markets.businessinsider.comHow to bet on Horse Racing: Complete guide to Horse Betting OnlineJanuary 3, 2023 | nypost.comSee More Headlines APHA Stock Analysis - Frequently Asked Questions How were Aphria's earnings last quarter? Aphria Inc. (NASDAQ:APHA) released its earnings results on Sunday, April, 11th. The company reported ($1.14) EPS for the quarter, missing the consensus estimate of ($0.04) by $1.10. The company's revenue was up 6.4% compared to the same quarter last year. Read the conference call transcript. What other stocks do shareholders of Aphria own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Tilray (TLRY), Cronos Group (CRON), NVIDIA (NVDA), Tesla (TSLA) and NIO (NIO). Company Calendar Last Earnings4/11/2021Today12/21/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & Botanicals Sub-IndustryN/A Current SymbolNASDAQ:APHA CUSIPN/A CIKN/A Webaphriainc.com Phone(844) 427-4742FaxN/AEmployees1,200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-63,210,000.00 Net Margins-36.10% Pretax MarginN/A Return on Equity-2.30% Return on Assets-1.66% Debt Debt-to-Equity Ratio0.25 Current Ratio2.36 Quick Ratio1.17 Sales & Book Value Annual Sales$405.96 million Price / Sales12.00 Cash Flow$0.09 per share Price / Cash Flow166.43 Book Value$4.80 per share Price / Book3.20Miscellaneous Outstanding Shares316,795,000Free FloatN/AMarket Cap$4.87 billion OptionableOptionable Beta2.67 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report This page (NASDAQ:APHA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aphria Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aphria With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APHA Stock Alerts